Active gene promoters are associated with covalent histone modifications, such as hyperacetylation, which can modulate chromatin structure and stabilize binding of transcription factors that recognize these modifications. At the β-globin locus and several other loci, however, histone hyperacetylation extends beyond the promoter, over tens of kilobases; we term such patterns of histone modifications "hyperacetylated domains". Little is known of either the mechanism by which these domains form or their function. Here, we show that domain formation within the murine β-globin locus occurs prior to either high-level gene expression or erythroid commitment. Analysis of β-globin alleles harboring deletions of promoters or the locus control region demonstrates that these sequences are not required for domain formation, suggesting the existence of additional regulatory sequences within the locus. Deletion of embryonic globin gene promoters, however, resulted in the formation of a hyperacetylated domain over these genes in definitive erythroid cells, where they are otherwise inactive. Finally, sequences within β-globin domains exhibit hyperacetylation in a context-dependent manner, and domains are maintained when transcriptional elongation is inhibited. These data narrow the range of possible mechanisms by which hyperacetylated domains form.
Introduction
A crucial feature of gene activation is the interaction between transcription factors and chromatin. All eukaryotic genomic DNA, with limited exceptions, is packaged with core histones to form chromatin. The fundamental subunit of chromatin is the nucleosome, consisting of ~147 bp of DNA wrapped in ~1.75 turns about an octamer of core histones; a variable length of linker DNA extends between nucleosomes, and can in turn be partially sequestered by interactions with core histone amino terminal "tail" regions and/or linker histones such as histone H1. The resulting structure, when observed on low-salt spreads by electron microscopy, has been termed "beads on a string" based on its appearance 1, 2 . At physiologically relevant salt concentrations, however, this structure spontaneously condenses, first to a helical array of nucleosomes termed the 30 nm fiber, then through additional levels of higher-order structure, which are not well understood 3 . Regardless, this packaging renders the eukaryotic DNA relatively inaccessible to transcription factors [4] [5] [6] .
The transcriptional machinery possesses mechanisms for modulating chromatin structure. One of these is covalent modification of core histones, including acetylation, methylation, phosphorylation, ubiquitylation, SUMOylation, ADP-ribosylation -in short, the gamut of modifications known to occur on cellular proteins. Different modifications can lead to different functional consequences. Histone acetylation is associated with transcriptional activation -in fact, core histones proximal to active gene promoters are universally hyperacetylated 7, 8 . Histone methylation can be associated with activation or repression, depending on the exact residue modified; methylation of lysine 4 of histone H3 is, like hyperacetylation, associated with active promoters, while methylation of lysine 9 of histone H3 localizes with repressive heterochromatin 9, 10 . Different histone modification patterns can stabilize or destabilize the interaction of transcription factors and thus mediate functional effects.
For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From The transcriptional regulation of the β-globin genes has been the subject of intense study for several decades. The mammalian β-globin genes are confined to a single cluster, and are expressed exclusively in erythroid cells. High-level β-globin gene expression requires sequences located 5' of the genes and termed the locus control region (LCR) 11 . Expression from within the cluster is developmentally regulated.
Initially during embryogenesis, immature primitive erythroblasts derived from the yolk sac enter the bloodstream as nucleated cells and differentiate as a semisynchronous cohort 12 . Subsequently, definitive erythrocytes, having matured and enucleated within the fetal liver or postnatal marrow, enter the circulation. Corresponding to these changes, mammals undergo a switch in globin gene expression upon the transition from primitive to definitive erythropoiesis, and some, including humans, have fetal-specific βglobin genes as well [13] [14] [15] .
Active β-globin gene promoters in erythroid cells are, as expected, associated with nucleosomes that exhibit hyperacetylation and dimethylation at histone H3 K4.
Within this locus, however, these modifications are not confined to promoter-proximal regions; each of the active genes resides within blocks of 11-12 kb or more within which all sequences are associated with hyperacetylated histones 15, 16 . We term these regions "hyperacetylated domains," although additional modifications, such as H3K4 dimethylation, co-map with histone acetylation 17 .
Genome-wide studies of histone modifications have demonstrated that hyperacetylated domains are not a general phenomenon 18, 19 . To date, all known examples of hyperacetylated domains occur over highly expressed, tissue-specific genes, most of which are also known to be controlled by distal enhancers 17, 20 . Within transgenic human growth hormone loci, for example, mutation of a pituitary enhancer ~15 kb 5' of the genes eliminates transcription and the hyperacetylated domain 21 . In For personal use only. on November 16, 2017. by guest www.bloodjournal.org From another study, histone modifications at the λ5/VpreB1 locus, active in pre-B lymphocytes, were monitored in cell lines modeling different stages of differentiation.
When the genes were maximally active in pre-B cells, they were also located within a hyperacetylated domain. Interestingly, histone hyperacetylation in embryonic stem (ES) cells was limited to a regulatory element located between the two genes; in cell lines modeling later stages of differentiation, the region associated with hyperacetylation appeared to spread outward from this site 22 .
Other than this correlation with tissue-specific gene activation by distal regulatory elements, our understanding of the formation and function of hyperacetylated domains is limited. We have therefore further examined the hyperacetylated domains that form within the murine β-globin locus in erythroid cells. Our results indicate that domain formation precedes both high-level β-globin expression and commitment to the erythroid lineage, suggesting that they are not a consequence of transcription but instead precede it. Deletions of the β-globin LCR or of individual β-globin gene promoters do not eliminate the domains, implying that DNA sequence requirements for domain formation reside elsewhere. On the other hand, we show that the embryonic β-globin gene promoters are required for suppression of domain formation over the embryonic genes in definitive erythroid cells, where these genes are normally silenced. We also demonstrate that histone hyperacetylation over at least some regions of the locus is not an intrinsic function of DNA sequences within these regions, but depends upon the presence of other sequences, or upon relative position within the locus. Coupled with the observation that inhibition of RNA polymerase II elongation has no effect on maintenance of histone hyperacetylation, our work narrows the range of potential models for domain formation, and provides support for a mechanism involving spreading of the histone modification signature from specific sequences. 
Materials and methods:

Cell culture
Cell lines were maintained at 37 º C in a 5% CO 2 -humidified atmosphere. MEL745a cells were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS), 1% Glutamax (Invitrogen) and 1% penicillin/streptomycin. For induction, 2% dimethyl sulfoxide (Sigma) was added to the culture medium. FDCP-Mix were cultured in Iscove's modified Dulbecco's medium (IMDM) with 20% horse serum (Invitrogen), 1% Glutamax, 1% penicillin/streptomycin and 10 ng/ml murine IL-3 (Peprotech).
Embryonic stem cell (ES) and embryoid body (EB) culture and differentiation
Murine ES cells were differentiated into embryoid bodies as previously described 23 . At day 2, 4, 6, and 8 of differentiation, EBs were dissociated with trypsin (Invitrogen) to give single-cell suspensions. These cells were harvested for RNA, ChIP, cell counts, and benzidine staining. Details of these protocols are listed below.
Collection of embryonic peripheral blood and fetal liver
Mice were mated overnight and the vaginal plug verified the next morning indicating E0.3. At E12.5 and E14.5, pregnant mice were sacrificed by cervical dislocation for collection of embryonic blood and fetal liver 12, 15 . Animal experiments were approved by the University Committee on Animal Resources (University of Rochester, Rochester, N.Y.).
Benzidine staining of embroid bodies
To identify heme-containing cells, trypsinized EBs were stained with benzidine dihydrochloride (Sigma) as described 24 and counted on a hemocytometer (VWR).
qRT-PCR
RNA was isolated using TRIzol (Invitrogen) according to manufacturer recommendations. 1 µg RNA was used to synthesize cDNA using the iScript cDNA For personal use only. on November 16, 2017. by guest www.bloodjournal.org From synthesis kit (Biorad). Reverse transcription was also performed without enzyme as a negative control. Primers used amplified εy-, βh1and combined β1and β2globin cDNAs. QuantiTect Primers (Qiagen) for 18S mRNA were used as an internal control.
cDNA was amplified using iQ SYBR green supermix (Biorad) and detected using the MyiQ Single Color Real Time PCR detection system and iCycler (Biorad).
Chromatin immunoprecipitation assay (ChIP)
Cells were formaldehyde crosslinked, sonicated and immunoprecipitated, and DNA isolated as previously described 16, 25 . Cells were washed with PBS and crosslinked at room temperature in 10 ml volume containing 1% formaldehyde. After addition of 0.5 ml 2.5 M glycine and a PBS wash, cells were resuspended in 3 ml and sonicated for a total of 80 seconds using a Misonix Sonicator 3000 (Farmindale, NY) at 36-39 W output. An "input" fraction was then removed to serve as a control. Antibodies used for immunoprecipitation were (1) normal rabbit IgG (Upstate) as a control; (2) anti-histone H3 acetylated at K9 and/or K16 (Upstate); (3) anti-histone H4 acetylated at K5, K8, K12, and/or K16 (Upstate); (4) anti-histone H3 dimethylated at K4 (Upstate and Abcam); (5) anti-histone H3 trimethylated at K4 (Upstate), and (6) anti-RNA Pol II (Santa Cruz).
Analysis was performed using qPCR as above. Primers were designed to amplify regions within the murine β-globin locus, and regions within loci that are inactive in erythroid cells as controls, including amylase, protamine, and T-cell receptor β-chain.
Primers and calculation of enrichments were described previously 15 
Results
Murine β-globin hyperacetylated domain formation precedes high-level expression and erythroid commitment. Hyperacetylated domains, each of which is at least 10 kb in extent, encompass the expressed β1and β2-globin genes in definitive erythroid cells from adult mice 16 . In primitive erythroid cells, where both the adult genes (at low levels) and the embryonic εyand βh1-globin genes are expressed, the individual β1and β2-globin domains are present, while the εyand βh1-globin genes reside within a distinct hyperacetylated domain of more than 19 kb 15 . In these studies, histone modifications were assayed using spleens from anemic adult mice or circulating primitive erythroblasts, both of which consist primarily of late-stage erythroid cells expressing high levels of β-globins.
To assay for hyperacetylated domain formation prior to high-level β-globin gene expression, we utilized murine erythroleukemia (MEL) cells. Under normal conditions of cell culture, MEL cells express low levels of the adult β1and β2-globin genes. When cultured in media containing 2% DMSO, however, MEL cells terminally differentiate, ceasing to proliferate and becoming visibly smaller and red with hemoglobin, reflecting an increase of 75-to 150-fold in adult globin mRNA levels ( Figure 1A-B ).
We analyzed histone acetylation and H3K4 dimethylation within the β-globin Lysines can be mono-, di-, or trimethylated, and for histone H3 K4, these methylation states occur with different patterns across the genome and active gene loci 9,10 . Previously we have examined solely H3K4 dimethylation, so we determined the pattern of H3K4 trimethylation across the β-globin locus in MEL cells. Unlike the dimethyl H3K4 pattern, we find significant levels of H3K4 trimethylation only within the transcribed regions of the β1and β2-globin genes, and then only in DMSO-induced MEL cells ( Figure 1E ). Uninduced MEL cells, expressing low levels of β-globin, show minimal H3K4 trimethylation even within the genes. Probes located at the promoters or downstream of the genes, or anywhere else in the locus, do not exhibit this modification.
This indicates that hyperacetylated domains are associated specifically with dimethyl H3K4.
In addition to MEL cells, we have examined histone modifications in factordependent cell Paterson mixed potential cells (FDCP-Mix), a murine bone marrowderived cell line that is commonly used as a model for multipotential myeloid progenitors 26 . These cells are not committed to differentiation along a particular pathway, and can be induced to differentiate into a variety of myeloid cell types, including erythroid; β-globin expression in these cells is extremely low ( Figure 1A ). In these cells, under non-differentiating conditions, we again observe hyperacetylated domains over the regions containing the adult β-globin genes ( Figure 1F ) that do not differ significantly from those observed in primary erythroid cells or MEL cells ( Figure   1E ). Taken together, these observations suggest that domain formation is independent of high-level β-globin gene expression and in fact precedes commitment to the erythroid lineage.
In murine embryonic stem (ES) cells, we do not observe appreciable enrichments for histone hyperacetylation or H3K4 dimethylation anywhere within the β-globin locus ( Figure 2A) , indicating that the hyperacetylated domains that form over the LCR and the active β-globin genes are established at a specific stage of development and/or differentiation. To examine this in more detail, we performed in vitro differentiation of murine ES cells by culturing them in suspension, which results in the formation of embryoid bodies (EBs) 23 The LCR is not continuous with the hyperacetylated domains encompassing the adult βglobin genes, but does appear to be continuous with the hyperacetylated domain encompassing the embryonic β-globin genes in primitive erythroblasts. Prior studies have shown that deletion of the LCR has no effect on histone modifications at the active β-globin gene promoters 25 , but the effect of the LCR deletion on the formation of hyperacetylated domains has not previously been determined.
We examined histone modifications across the β-globin locus in mice homozygous for the LCR deletion; this deletion is lethal in mice, but is rescued by a transgenic human β-globin locus 11, 27 . ChIP assays were performed using E12.5 embryonic blood ( Figure 3A ) and E14.5 fetal liver ( Figure 3B ), representing primitive and definitive erythroid cells, respectively. On β-globin alleles lacking the LCR, histone hyperacetylation and H3K4 dimethylation occur in domains encompassing both the embryonic εyand βh1-globin genes and the adult β1and β2-globin genes in primitive erythroid cells. In definitive erythroid cells, only the domains encompassing the β1and β2-globin genes are present.
These patterns of histone modification are similar to those observed at the wildtype β-globin locus (Figure 3 ), suggesting that the LCR is not required for domain formation over any of the β-globin genes. Notably, however, probes that are normally interposed between the LCR and the εy-globin gene are not hyperacetylated in the absence of the LCR in either primitive or definitive erythroid cells (Figure 3 ). This region exhibits hyperacetylation and H3K4 dimethylation at both developmental stages in the wildtype allele, suggesting that histone modifications associated with these sequences are LCR-dependent. Furthermore, sequences located between the LCR and the εyglobin gene are apparently not part of the hyperacetylated domain encompassing the embryonic β-globin genes in primitive erythroblasts, and are part of a distinct domain that includes the LCR.
Domain formation does not require the embryonic β-globin gene promoters. Based partly on the absence of a role for the LCR, we hypothesize that DNA sequences required for the formation of hyperacetylated domains will reside within or at the boundaries of the domains themselves. The β-globin gene promoters are the most obvious candidate sequences. As such, we examined histone modifications across β-globin loci harboring deletions of the embryonic β-globin gene promoters.
Targeted deletion of the εyand βh1-globin gene promoters, alone and in combination, has been performed previously 28, 29 (Figure 4A ). In agreement with these studies, we find that each promoter deletion eliminates expression of the corresponding β-globin gene, but expression of the other globin genes is either not affected (εy in the βh1 promoter deletion, βh1 in the εy promoter deletion), or slightly affected (β1/β2 expression in the εy/βh1 double promoter deletion) ( Figure 4B ).
We performed ChIP analysis of these β-globin alleles using E12. Figure 5B ). We observe no significant changes in histone hyperacetylation or H3K4 dimethylation on the allele lacking the βh1-globin promoter, indicating that the εy-globin promoter is sufficient to suppress domain formation.
Deletion of the εy-globin promoter alone, however, does not have the same effect as deletion of both promoters; on this allele, significant enrichments for histone hyperacetylation and H3K4 methylation extend from the εy-globin gene to 7-8 kb 3' of the deletion, and no further. This partial restoration of the domain suggests that the βh1globin promoter suppresses domain formation in definitive erythroid cells, even though its deletion has no effect by itself.
The mouse β-globin allele on which the embryonic β-globin promoter deletions were performed contains an additional gene, βh0, downstream of εy-globin. In primitive erythroblasts, βh0 is upregulated upon deletion of the εy-, but not the βh1-globin, promoter, which likely reflects transcriptional interference from the εy-globin gene 29 . In definitive erythroid cells, however, we cannot detect βh0 expression from the allele lacking the εyand βh1-globin gene promoters (data not shown), indicating that domain formation is insufficient for βh0 expression, and that βh0 transcription is still suppressed by other mechanisms. This also demonstrates that domain formation is not a consequence of transcription of any of the embryonic β-globin genes.
An intergenic sequence exhibits histone modifications in a positiondependent fashion.
In considering mechanisms by which a hyperacetylated domain might form, it is possible that all sequences within a domain comprise regulatory regions that recruit histone modifying complexes; we term this mechanism "mass action".
Histone hyperacetylation and H3K4 dimethylation associated with sequences located between the LCR and the εy-globin gene, however, require the presence of the LCR (Fig. 3) , arguing against this model.
In addition, we tested the "mass action" model by comparison of the naturallyoccurring D and S alleles of the β-globin locus in mice. Restriction site polymorphisms between these alleles have been used previously to distinguish between transcripts originating from D vs. S β-globin loci 11 . Such polymorphisms occur within noncoding regions as well, and repetitive sequences (LINE, SINE, etc.) occur with different patterns. In particular, a 6 kb insertion is present in the D allele between the β1and β2globin genes; this insertion is not present in the S allele, which instead harbors a different insertion between the β1and β2-globin genes of 7 kb. The insertion sites on the two alleles are not identical, resulting in a different location, relative to the two adult β-globin genes, for a region of ~1.4 kb of unique sequence; this region is located closer For personal use only. on November 16, 2017. by guest www.bloodjournal.org From to the β2-globin gene on the D allele and closer to the β1-globin gene on the S allele ( Figure 6A ).
ChIP analysis of the D and S alleles shows that chromatin within this region is
differentially modified (Figure 6B ). On the D allele, this sequence is located ~2 kb 5' of the β2-globin gene promoter, and ~10 kb 3' of the β1-globin gene. In this position, it does not exhibit histone hyperacetylation or H3K4 dimethylation; it is apparently too far 3' of the β1-globin domain and outside the 5' boundary of the β2-globin domain. On the S allele, this sequence is located 3-4.4 kb 3' of the β1-globin gene and 8.2-9.6 kb 5' of the β2-globin gene. In this position, it exhibits histone hyperacetylation and H3K4 dimethylation as part of the β1-globin hyperacetylated domain. These data suggest that histone hyperacetylation in erythroid cells is not an intrinsic function of this sequence, but is position-dependent and directed by neighboring sequences.
Hyperacetylated domains are maintained in the absence of elongation by
RNA polymerase II. If the modification state associated with some sequences within the domain is not intrinsic to those sequences, it follows that it is a consequence of regulatory phenomena that originate elsewhere and establish a chromatin modification pattern that then spreads to include these sequences. Among potential "spreading" models for domain formation, an attractive possibility involves elongation by RNA polymerase II. This model originates from two observations: (1) at the human β-globin locus, and elsewhere, transcription is not limited to the genes but occurs throughout intergenic regions as well, although the function of such transcription is unknown 31-34 ; (2) histone acetyltransferases and methyltransferases interact with elongating RNA polymerase II 35, 36 . Thus hyperacetylated domains could form via transcriptional elongation within the β-globin locus. Previously, however, it has been demonstrated that For personal use only. on November 16, 2017. by guest www.bloodjournal.org From incubation of MEL cells in DRB, an inhibitor of RNA polymerase II elongation, has no effect on histone modifications over the β1-globin gene in MEL cells 37 .
To extend this observation, we isolated E12.5 mouse embryonic blood, which consists almost exclusively of primitive erythroid cells, and incubated them in DRB.
Under these conditions, primary βh1-globin transcript levels decreased drastically, while mature (spliced) transcript levels were unaffected, as expected given the stability of mature β-globin mRNA ( Figure 7A ). Occupancy of the β-globin promoters by RNA polymerase II was unaffected, as demonstrated by ChIP, but polymerase levels were reduced within the εyand βh1-globin genes, as expected in the absence of elongation ( Figure 7B ). Under these conditions, we observed no significant change in histone hyperacetylation or H3K4 methylation across the embryonic domain, compared to cells in the absence of DRB ( Figure 7C ). Given the dynamic nature of histone acetylation, this suggests that maintenance of the hyperacetylated domain does not require elongation by RNA polymerase II, and thus that the histone modification pattern characteristic of the hyperacetylated domain spreads by a distinct mechanism.
Discussion
Based on genome-wide studies of histone modifications in mammalian cells, hyperacetylated domains seem to occur over a small proportion of active gene loci, at least in the cell types examined so far 18, 19 . As a general rule, histone hyperacetylation and H3K4 dimethylation occur at active gene promoters, with modification levels returning to background within a few hundred base pairs to either side, suggesting that only the most proximal nucleosomes are modified 18, 19, 35 . Among published examples of hyperacetylated domains, all are associated with tissue-specific genes under the control of distal regulatory elements like enhancers. Perhaps the most striking example of this specificity is provided by the mammalian α-globin gene cluster. This locus is embedded within a region containing several genes that are constitutively expressed in a wide range of tissues. Despite this arrangement, a hyperacetylated domain forms only in erythroid cells, encompassing the α-globin cluster and regulatory elements located within the introns of a neighboring gene 38 .
The models provided by the MEL and FDCP-Mix cell lines suggest that the hyperacetylated domains within the β-globin locus in erythroid cells are established well before high-level transcription occurs, and even before commitment to the erythroid lineage. This argues against a mechanism in which hyperacetylated domains are a consequence of high-level transcription during terminal differentiation, although it does not rule out a role for transcription per se, since the β-globin genes are transcribed at low levels in these cell lines. In addition, the timing of domain formation remains to be determined in primary erythroid cells, which could differ from the immortalized or transformed lines we employ here. Regardless, coupled with the fact that domain formation is limited to a minority of gene loci, the available evidence suggests that hyperacetylated domains represent a specific and regulated feature of the activation of certain genes.
Our data provide a basis for differentiating between mechanisms for domain formation. The modification state of nucleosomes located 5' of the εy-globin gene promoter is LCR-dependent; we also find that a sequence located between the β1and β2-globin genes exhibits different histone modification states on different alleles, within which it resides in different relative locations. Thus, the modifications exhibited by histones at specific sequences is dependent upon their context. These results suggest For personal use only. on November 16, 2017. by guest www.bloodjournal.org From that histone modifications associated with these sequences are a downstream consequence of regulatory phenomena that originate elsewhere.
It has been speculated that non-genic/intergenic transcription could account for the spread of histone modifications, but we demonstrate that the domains are unaffected by inhibition of RNA polymerase II elongation with DRB 31, 32, 34 . Our DRB incubation times -15 min. in Fig. 7 , but for up to 4 hrs. (data not shown) -are sufficient to demonstrate that maintenance of histone hyperacetylation does not require RNA polymerase elongation, since this modification is highly dynamic; a typical acetylation event lasts approximately 5-15 minutes [39] [40] [41] . Hyperacetylated domains are also associated with histone H3K4 dimethylation, however, which is more stable, and in fact may not be removed in the absence of cell division 9 . It is therefore possible that this modification depends upon RNA polymerase II elongation, although then the maintenance of histone hyperacetylation would require this or another stable modification, either for active recruitment of histone acetyltransferases or to inhibit histone deacetylases.
We find that the embryonic β-globin gene promoters are not required for formation of the hyperacetylated domain encompassing these genes, suggesting that sequence determinants of domain function reside elsewhere. This result also argues against a role for genic transcription in domain formation, although we cannot rule out a role for transcription per se, since the βh0-globin gene is transcribed on the allele harboring the εyand βh1-globin promoter deletions.
Interestingly, we find that a hyperacetylated domain forms over this region in definitive erythroid cells on the allele lacking the εyand βh1-globin gene promoters; on this allele the βh0 promoter is still intact, but we are unable to detect any transcription.
Taken together, the data suggest that the domain is governed by a regulatory sequence distinct from the promoters. This activity is suppressed by the embryonic promoters in definitive erythroid cells, but in the absence of these sequences it is still functional. The identity of this sequence is not known, but we note that upon deletion of the εy-globin gene promoter, the domain is partially restored, extending from the gene to a region 7-8 kb 3' of the deletion, where it abruptly ends. This region therefore represents a candidate for a cis-acting sequence element involved in domain formation.
The establishment of a hyperacetylated domain over the embryonic β-globin genes in definitive erythroid cells in the absence of the gene promoters has ramifications for the mechanism by which these genes are developmentally silenced. Previously, it has been shown that incubation of erythroid cells from E14.5 fetal liver with histone deacetylase inhibitors results in an increase in histone acetylation levels at the εy-globin promoter, suggesting that histone deacetylase activity is recruited there 42 . Our results indicate that the embryonic β-globin gene promoters are required for recruitment throughout the domain. Given that we do not observe any transcription originating from the intact βh0-globin gene promoter, domain formation appears to be insufficient to achieve embryonic β-globin gene activation in definitive erythroblasts. The lack of detectable transcripts, however, suggests that domain formation is a prerequisite to gene activation, not a consequence.
Our results, along with previous studies, suggest that hyperacetylated domains represent a regulated feature of the activation of specific gene loci. Notably, the bestsupported model for formation of heterochromatic domains involves the nucleation of heterochromatin at specific sequences, which then spreads bidirectionally to encompass neighboring sequences as well. As yet, however, we cannot conclude that hyperacetylated domains are formed by a completely analogous mechanism. It remains to be determined what cis-acting regulatory sequences govern domain formation and maintenance, and the function they provide in gene activation. For personal use only. on November 16, 2017. by guest www.bloodjournal.org From Asterisks denote enrichments observed for the translocated unique sequence common to D and S, while an "X" denotes enrichment observed for the sequence unique to D. For personal use only. on November 16, 2017. by guest www.bloodjournal.org From
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